Active Ingredient: LEVOCETIRIZINE DIHYDROCHLORIDE
Proprietary Name: XYZAL
Dosage Form; Route of Administration: SOLUTION; ORAL
Strength: 2.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N022157
Product Number: 001
Approval Date: Jan 28, 2008
Applicant Holder Full Name: CHATTEM INC DBA SANOFI CONSUMER HEALTHCARE
Marketing Status:
Discontinued
Patent and Exclusivity Information
